Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCBC
1201
DELISTED
Macatawa Bank Corp
MCBC
| $10.3M | 0.01% |
1,323,462
-700
| -0.1% | -$5.07K |
|
1202
Vitamin Cottage Natural Grocers
NGVC
$641M
| $10.3M | 0.01% |
694,615
+127,600
| +23% | +$1.55M |
|
|
TWOU
1203
DELISTED
2U Inc
TWOU
| $10.3M | 0.01% |
+9,047
| New | +$8.08M |
|
1204
Compañía de Cervecerías Unidas
CCU
$2.16B
| $10.3M | 0.01% |
718,933
+246,600
| +52% | +$3.55M |
|
1205
Vertiv
VRT
$113B
| $10.3M | 0.01% |
+759,000
| New | +$8.84M |
|
1206
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $10.3M | 0.01% |
+94,200
| New | +$9.75M |
|
1207
G. Willi-Food International
WILC
$394M
| $10.3M | 0.01% |
659,768
-1,794
| -0.3% | -$23.6K |
|
1208
Exelon
EXC
$47B
| $10.3M | 0.01% |
397,220
-2,415,342
| -86% | -$64.1M |
|
1209
Zurn Elkay Water Solutions
ZWS
$8.38B
| $10.2M | 0.01% |
729,699
+644,390
| +755% | +$8.45M |
|
1210
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.5B
| $10.2M | 0.01% |
145,000
+97,500
| +205% | +$6.86M |
|
|
DAO
1211
Youdao
DAO
$2.15B
| $10.2M | 0.01% |
272,300
+223,700
| +460% | +$5.5M |
|
1212
Ingredion
INGR
$6.61B
| $10.2M | 0.01% |
122,500
-71,400
| -37% | -$5.84M |
|
|
FONR
1213
DELISTED
Fonar
FONR
| $10.2M | 0.01% |
475,491
-33,725
| -7% | -$689K |
|
|
SPPI
1214
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $10.1M | 0.01% |
3,002,073
+744,331
| +33% | +$2.17M |
|
1215
Western New England Bancorp
WNEB
$278M
| $10.1M | 0.01% |
1,751,139
-1,850
| -0.1% | -$10.3K |
|
1216
Perion Network
PERI
$384M
| $10.1M | 0.01% |
1,937,139
-246,034
| -11% | -$1.26M |
|
1217
Benchmark Electronics
BHE
$2.96B
| $10.1M | 0.01% |
468,300
-11,500
| -2% | -$241K |
|
|
AXON
1218
Axon Enterprise
AXON
$49B
| $10.1M | 0.01% |
102,952
-11,000
| -10% | -$889K |
|
|
DENN
1219
DELISTED
Denny's
DENN
| $10.1M | 0.01% |
999,200
-1,345,711
| -57% | -$13.8M |
|
|
HCCI
1220
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $10.1M | 0.01% |
577,200
-41,430
| -7% | -$698K |
|
1221
Community Trust Bancorp
CTBI
$1.43B
| $10M | 0.01% |
306,382
-18,723
| -6% | -$602K |
|
1222
Tejon Ranch
TRC
$444M
| $10M | 0.01% |
695,378
+147,379
| +27% | +$2.05M |
|
1223
Gerdau
GGB
$9.32B
| $9.99M | 0.01% |
4,251,114
-1,912,538
| -31% | -$3.63M |
|
|
HUD
1224
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $9.98M | 0.01% |
2,048,526
+336,986
| +20% | +$1.76M |
|
1225
Universal Electronics
UEIC
$68.5M
| $9.96M | 0.01% |
212,800
+13,100
| +7% | +$551K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.